The Official Medicare Set Aside Blog And Information Resource

Medicare Secondary Payer Recovery Portal Webinar Slides Available

CMS, Conditional Payments, Medicare Secondary Payer Recovery Portal on March 26, 2019
Posted by Jean S. Goldstein, JD

The slides from a recent webinar held by the Centers for Medicare and Medicaid Services (CMS) regarding the upcoming enhancement to the Medicare Secondary Payer Recovery Portal (MSPRP) allowing electronic payments are now available, and can be viewed here.  As we discussed recently here on our blog, Non-Group Health Plans (liability insurers (including self-insurers), no-fault […] Continue

MSP Compliance Continues to be Placed at the Forefront

Conditional Payments, Medicare, MSP News on March 20, 2019
Posted by Jean S. Goldstein, JD

On Monday, the U.S. Department of Justice’s (DOJ) Attorney’s Office for the District of Maryland issued a press release concerning a settlement arrangement involving the repayment of conditional payments with the law firm of Meyers, Rodbell & Rosenbaum, P.A., a firm based out of Maryland.  The law firm entered into the settlement agreement to resolve […] Continue

MSPRP E-Payments Go Live On April 1, 2019

CMS, Conditional Payments, Medicare Secondary Payer Recovery Portal on March 14, 2019
Posted by Jean S. Goldstein, JD

Yesterday, the Centers for Medicare and Medicaid Services (CMS) held a high level overview webinar of changes coming to the Medicare Secondary Payer Recovery Portal (MSPRP), as we recently discussed here on our blog.  The webinar addressed the most recent upcoming enhancement, which will allow electronic payments to be submitted directly through the MSPRP.  As […] Continue

FDA Approves Esketamine Nasal Spray (Spravato™) for Treatment-Resistant Depression

FDA, MSAs, Rx/Pharmacy on March 13, 2019
Posted by Leah King, PharmD, JD, Independent Pharmacy Consultant

Earlier this month, the Food and Drug Administration (FDA) approved esketamine nasal spray, which will be marketed by Johnson & Johnson (J&J) under the trade name of Spravato™. Spravato is approved for use in conjunction with an oral antidepressant for treatment-resistant depression. The term “treatment-resistant” refers to those patients who have failed to achieve relief […] Continue

Efforts to Streamline the Conditional Payment Recovery Process Continue, Amidst Confirmation of Ramp up from the CRC

CMS, Conditional Payments, Medicare Secondary Payer Recovery Portal on March 5, 2019
Posted by Jean S. Goldstein, JD

Last week, the Centers for Medicare & Medicaid Services (CMS) announced two upcoming webinars, aimed at addressing payment functionalities within both the Medicare Secondary Payment Recovery Portal (MSPRP) and Commercial Repayment Center Portal.  These latest enhancements to the conditional payment recovery process will enable users of the CMS maintained portals to make electronic payments for […] Continue